Camerone Eleonora Maria, Tosi Giorgia, Romano Daniele
Department of Psychology, University of Milano-Bicocca, Milano, Italy.
Nuffield Department of Clinical Neuroscience, University of Oxford Oxford, United Kingdom.
Pain. 2025 Jan 9;166(7):1577-1586. doi: 10.1097/j.pain.0000000000003495.
Placebo hypoalgesia and nocebo hyperalgesia, which exemplify the impact of expectations on pain, have recently been conceptualised as Bayesian inferential processes, yet empirical evidence remains limited. Here, we explore whether these phenomena can be unified within the same Bayesian framework by testing the predictive role of expectations and their level of precision (ie, expectation confidence) on pain, with both predictors measured at the metacognitive level. Sixty healthy volunteers underwent a pain test (ie, 8 noxious electrical stimuli) before (Baseline) and after (T0, T1, T2) receiving a sham treatment associated with hypoalgesic (placebo), hyperalgesic (nocebo), or neutral (control) verbal suggestions, depending on group allocation. Trial-by-trial expectations, their precision, and perceived pain were measured. Skin conductance response (SCR) was also recorded as an autonomic response marker. Bayesian linear mixed models analyses revealed that, for both placebo and nocebo, pain was predicted by expectations alone and by their interaction with expectations precision. In addition, the discrepancy between expected and perceived pain was predicted by expectation precision, with greater alignment between expected and perceived pain when precision was higher. This suggests that both placebo and nocebo responses are well described from a Bayesian perspective. A main effect of time for SCR was observed, suggesting habituation to painful stimuli. Our data provide evidence indicating that both placebo hypoalgesia and nocebo hyperalgesia can be unified within the same Bayesian framework in which not only expectations but also their level of precision, both measured at the metacognitive level, are key determinants of the pain inferential process.
安慰剂性痛觉减退和反安慰剂性痛觉过敏体现了期望对疼痛的影响,最近被概念化为贝叶斯推理过程,但实证证据仍然有限。在此,我们通过测试期望及其精确程度(即期望置信度)对疼痛的预测作用,来探究这些现象是否能在同一个贝叶斯框架内统一起来,这两个预测因素均在元认知水平上进行测量。60名健康志愿者在接受与痛觉减退(安慰剂)、痛觉过敏(反安慰剂)或中性(对照)言语暗示相关的假治疗之前(基线)和之后(T0、T1、T2),根据分组进行了疼痛测试(即8次有害电刺激)。逐次试验的期望、其精确程度和感知到的疼痛都进行了测量。皮肤电导反应(SCR)也作为自主反应标记进行了记录。贝叶斯线性混合模型分析显示,对于安慰剂和反安慰剂而言,疼痛仅由期望以及期望与期望精确程度的相互作用来预测。此外,期望精确程度预测了预期疼痛与感知疼痛之间的差异,当精确程度较高时,预期疼痛与感知疼痛之间的一致性更强。这表明从贝叶斯角度可以很好地描述安慰剂和反安慰剂反应。观察到SCR随时间的主效应,表明对疼痛刺激产生了习惯化。我们的数据提供了证据,表明安慰剂性痛觉减退和反安慰剂性痛觉过敏都可以在同一个贝叶斯框架内统一起来,在这个框架中,不仅期望,而且在元认知水平上测量的期望精确程度,都是疼痛推理过程的关键决定因素。